ExploreOutcomeFamily conflict
Outcome

Family conflict

Also known as: Conflict, Family Conflicts, Family Family Conflict Family Conflicts Family conflict Family conflict (Conflict Behavior Questionnaire) over 24 months Family conflict (Conflict Behavior Questionnaire, averaged parent and adolescent scores) Family conflict (finding)
12 findings 1 paper 8 related entities View in graph →

Related entities

interventions
conditions
populations
studys

Findings (50)

None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
decline

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Size: F(6,383)=3.66 (anxiety x time interaction)
None
improvement

Bipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to

Effect: improvement; F(6,382)=2.29

Size: F(6,382)=2.29
None
improvement

Bipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to

Effect: improvement; F(6,382)=2.29

Size: F(6,382)=2.29
None
improvement

Bipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to

Effect: improvement; F(6,382)=2.29

Size: F(6,382)=2.29
None
improvement

Bipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to

Effect: improvement; F(6,382)=2.29

Size: F(6,382)=2.29
None
improvement

Bipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to

Effect: improvement; F(6,382)=2.29

Size: F(6,382)=2.29
None
improvement

Bipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to

Effect: improvement; F(6,382)=2.29

Size: F(6,382)=2.29
None
improvement

Bipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to

Effect: improvement; F(6,382)=2.29

Size: F(6,382)=2.29
None
improvement

Bipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to

Effect: improvement; F(6,382)=2.29

Size: F(6,382)=2.29
None
improvement

Bipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to

Effect: improvement; F(6,382)=2.29

Size: F(6,382)=2.29
None
improvement

Bipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to

Effect: improvement; F(6,382)=2.29

Size: F(6,382)=2.29
None
improvement

Bipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to

Effect: improvement; F(6,382)=2.29

Size: F(6,382)=2.29
None
improvement

Bipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to

Effect: improvement; F(6,382)=2.29

Size: F(6,382)=2.29
None
improvement

Bipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to

Effect: improvement; F(6,382)=2.29

Size: F(6,382)=2.29
None
improvement

Bipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to

Effect: improvement; F(6,382)=2.29

Size: F(6,382)=2.29
None
improvement

Bipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to

Effect: improvement; F(6,382)=2.29

Size: F(6,382)=2.29
None
improvement

Bipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to

Effect: improvement; F(6,382)=2.29

Size: F(6,382)=2.29
None
improvement

Bipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to

Effect: improvement; F(6,382)=2.29

Size: F(6,382)=2.29
None
improvement

Bipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to

Effect: improvement; F(6,382)=2.29

Size: F(6,382)=2.29
None
improvement

Bipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to

Effect: improvement; F(6,382)=2.29

Size: F(6,382)=2.29
None
improvement

Bipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to

Effect: improvement; F(6,382)=2.29

Size: F(6,382)=2.29
None
improvement

Bipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to

Effect: improvement; F(6,382)=2.29

Size: F(6,382)=2.29
None
improvement

Bipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to

Effect: improvement; F(6,382)=2.29

Size: F(6,382)=2.29
None
improvement

Bipolar adolescents with comorbid ADHD who received FFT-A showed reductions in family conflict that converged with the non-ADHD group by the end of the study, while those with ADHD in EC continued to

Effect: improvement; F(6,382)=2.29

Size: F(6,382)=2.29

Papers (1)